Biomendex
Tampere
About Biomendex
Biomendex develops and manufactures adaptable synthetic bone substitute materials for bone regeneration. Their invention, Adaptos®, is the first bioactive bone graft substitute that surgeons can cut, shape or squeeze into place. It is the only bone graft substitute that mimics bone by being resilient and bioactive. Adaptos® bone graft substitutes are being developed for clinical and veterinary use.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.5M
- Last round: Grant (Sep 2019)
- Website: biomendex.com
- Phone: +358405398799
Industries & Categories
Biotechnology, Health Care, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/biomendex-154381 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.